Additionally, BDNF stimulation has been observed to induce the de-phosphorylation of tau, another protein implicated in AD pathology, and to redirect amyloid precursor protein (APP) processing toward a non-amyloidogenic pathway (Jiao et al., 2016; Nigam et al., 2017). This evidence concerns the gene APP and Alzheimer disease.